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The combined effects of ACTH, ,0-endorphin (p-EP) and x-MSH were studied on the corticosteroidogenesis of isolated 1-t adrenocortical zona 
ksciculata and rona glomerulosa cells. P-EP potcntiated the effects of ACTH and a-MSf-l on the zona fasciculata corticostcronc production but 
inhibited those on thcxona glomerulosa aldostcrone production.&EPdid not alTect he combined action of4xlO-I’ M ACTH and 5x10-’ M a-MSH 
on the zona fasciculata or the zona glomerulosa cells, but it inhibited the stinlulatory action of the combination of I.GxlO-lo M ACTH and IO* 
M a-MSH on the zona glomerulosa aldosterone production. An interaction of ACTH. /3-EP and a-MSH in relation to the zona l’asciculata and 
zone glomcrulosa corticosteroid production was found, 
ACTH: ,&Endorphin; a-MSH: Proopiomclanocortin; Adrenocortical Steroidogcnesb; Aldosterone 
1. INTRODUCTION 
Proopiomelanocortin (POMC)-derived peptides have 
different effects on adrenocortical steroidogencsis. /3-EP 
is claimed to have stimulatory [1,2], khibitory [3] or no 
effect at all [4] (for a review, see [S]). a-MSH in low 
doses stimulates the zona glomerulosa ldosterone pro- 
duction selectively [6,73 and potentiates the effect of 
ACTH on both the zona fasciculata corticosterone pro- 
duction and the zona glomcrulosa ldosterone produc- 
tion [7]. As all of these peptides are present in the plas- 
ma, the question arises of how they act together on 
adrenocortical steroidogenesis. 
ACTH, a-MSH and /?-EP were added in different 
combinations and doses to isolated rat adrenocortical 
zona fasciculata nd zona glomerulosa cells. 
2. EXPERlMENTAL 
Male CFY rats weighing 200-250 g were used. The rut adrenal cell 
preparation applied in cur laboratory was described previously [S]. 
Briefly, cell suspensions wcrc prepared by collagenesc digestion of 
adrenal capsular strippings to yield zone glomerulosa cells. and of 
decapsulatcd adrenal glands to yield zona fasciculata cells. The zona 
fasciculatu cell conlamination in the zona glomerulosa ccl1 suspension 
was less than 5%. In general. adrenal glands from 40 rats were digested 
tor each adrenal cell prcparution. The cells were prepared in Krebsm 
Ringer bicarhonatc buffer (pH 7.4) containing 2 g/I glucose and 40 B/I 
human serum albumin [I-ISA). Forty zona glomerulosa and 40 zona 
fdsciculatn (0.9 ml)ccll suspension aliquols(approxin~atcly 3x105 cellsl 
ml) were incubated in one session. in a shaking water-bath at 37°C 
Corwqmd~~~ uddrcss: K. Sz. Szalay, Institute of Experimcnral Me- 
dicine, Hungarian Academy of Sciences. H-1450 Budapest. PO6 67. 
Hungary. 
under an atmosphere of 95% 0: and 5% CO2 for 2 IL ACT H (synthetic 
liumaa ah’-3U-ACTH (National Institute of Arthritis and Metabolic 
Diseases, NIH, Bethesda, MD, USA). synthetic human B-EP (Na- 
tional Institute of Mental Health, Rockvillc. MD, USA) and a-MSH 
(Reanul, Hungary) were dissolved in physiological saline containing 
5 g/l HSA and adjusted to pM 3.5. The concentrations of ACTH vvcrc 
4x10”’ and 1.6x10-~” M, thatof/ZPwas 10’iOM and thoseofa-MSH 
1verc IO” M and 5xlCrv M. Expcrimcnts were performed in u ran- 
domized block format to eliminate bias due to systemtitic error. The 
rxperimcnts were carried out with 3 or 4 incubations in duplicate or 
triplicate at each dose. 
The corticosteronc contents of the incubation media (both zone 
glomorulosa nd rona faseiculats) were determined by fluorimctry [9] 
after chloroform extraction. Aliquotsof thcchlorofom~ extracts ofthe 
glomcrulosa incubates were assayed for aldostcronc content by ra- 
dioimmunoussay without chromatographic scpamtion [8]. 
Statistical tlnalysis: 3-way analysis of sariancc was used for the 
logarithms of the data, and because of the signilicant interactions 
Dunncontrasts [IO] were used to dctcct signilicantdiffcrcnccs brtwecn 
means. 
3. RESULTS 
Tables I and II show all the experimental data. B-EP 
(IWOM) alone had no effect or slightly stimulated the 
zona fasciculata corticosterone production whereas it 
inhibited the zona glomerulosa ldosteronc production. 
a-MSH alone and ACTH alone each stimulated the 
hormone production of both cell types. B-EP poten- 
tiated the effect of ACTH on the zona fasciculata 
corticosterone production but inhibited that on the 
zons glomerulosa aldosterone production. j?-EP had no 
effect or slightly potentiated the effect of a-MSH on the 
zone fasciculata corticosterone production bum in- 
hibited that on the zona glomerulosa aldosterone 
production, /?-EP did not affect the combined action of 
87 
Volume 296, number 1 FEBS LETTERS January 1992 
Table I 
Treatment Zona fasciculatn Zona Slomcrulosa 
corticosteronc aldostcrone 
(pmoVmU2 h) (fmoVml/2 II) 
vehicle 
p.EP 
a-MSH, 
/I-W + a-MSH, 
ACTHLI 
a.-MSH,+ACTH2 
j-EP+a-MSH,+ACTH2 
(A) 155.1 (12)+ 
[5.044 k 0.0021 
(B) 160.2 (12) (J) 5938 (12) 
[5.076 f O,oOOS] [8.689 1 0.0025] 
(C) 198.3 (12) 
[5.290 -c O.cw] 
(K) 14220 (12) 
[9.562 1 0.0027] 
(D) 209. I (14) 
[5.343 f 0.0047] 
(E) 221.4 (12) 
[5.400 t 0.019] 
(F) 2G5.7 (12) 
[5.582 f 0.0291 
(cl) 338.3 (12) 
[5.824 + 0.01 l] 
(H) 335.1 (14) 
[5.814 f 0.0121 
(I) 6417 (13) 
[8.767 I 0.031 
(L) 12676 (13) 
[9.447 t O,OD3G] 
(M) 15530 (I?) 
[9.651 f 0.0093] 
(N) 12535 (1 I) 
[9.43B + 0.01 l] 
(0) 28234 (I 2) 
[IO.25 4 0.017] 
(P) 27809 (I 3) 
[IO.23 ” O.OOl?] 
Values geometric means ofdata; n is given in parentheses); [arithmetic 
means and SE of log data]. 
doses: j-EP= lo”’ M; a-MSH,=SxlO” M; ACTHl=4x10”1 M. 
P<O.OT: G-D 
PcO.01: A-C, B-D, E-F, E-G, F-H, A-E, B-F, C-G, D-H, I-J, K-L, 
I-K, J-L, M-N, M-O, N-P, I-M, J-N, K-O, L-P. 
4x10”’ M ACTH and 5~10’~ M cr-MSH on the zona 
fasciculata or the zona glomcrulosa cells, but it in- 
hibited the stimulatory action of the combination of 
1.6~10”~ M ACTH and IO” M cc-MSH on the zona 
glomerulosa ldosterone production. 
4. DISCUSSION 
Although the effects of ,&EP and a-MSM on adreno- 
cortical steroidogenesis have been studied in detail 
[3,6,7], the,re are scarcely any data op. the combined 
effects of .ihe POMC peptides ACTH, fi-EP and a- 
MSI-I. 
Similarly as demonstrated by our earlier results [73, 
a-MSH increased adrenocortical steroidogenesis in 
both the ;!ona fasciculata and the zona glomerulosa 
cells. The sensitivity of the zona glomerulosa cells to 
a-MSH is higher: lower doses that do not affect the 
zona fasciculata corticosterone production increase the 
aldosterone production of the zona glomerulosa cells, 
and therefore a specific aldosteronotropic effect has 
been suggested [6,7]. 
The effect of b-EP on adrenocortical steroidogenesis 
is controversial; it depends on the functional state of the 
adrenocortical cells [S]. In our present experiments, the 
effect of lo”O M B-EP on the zona fasciculata cells was 
stimulatory, while that on the zona glomerulosa cells 
was inhibitory, regardless of whether it was added alone 
or together with ACTH or a-MSH. 
Goverde t al. [ 1 I] found no effect ofp-EP on a-MSH 
or ACTH-induced corticosteroidogenesis in purified 
isolated adrenocortical cells. The discrepancy between 
their results and ours can be explained by the difference 
in the cell preparations used. 
Numerous data have been reported on the interac- 
tions of POMC peptides in relation to other endocrine 
systems. Khorram and McCann [12] showed that a- 
MSH acts as an antagonist o p-EP in regard to the 
secretion of prolactin whereas it potentiates the effects 
of p-EP in stimulating growth hormone secretion and 
inhibiting LH secretion. However, the experiments of 
Wardlaw and Ferin [ 131 indicated that a-MSH antago- 
nizes the action of/I-EP on both pituitary prolactin and 
LH release in the primate. In the presence of oc-MSH, 
lo’? P-EP (which itself had no effect) stimulated somato- 
statin release [14]. a-MSH prevents the inhibitory effect 
of B-EP on sexual behaviour [151. 
Our results how that the adrenocortical ction of one 
POMC-derived peptide may be influenced by the simul- 
Table II 
Trcntment Zona fitsciculata Zona glomerulosa 
corticosterone aldosterone 
(pmol/mK? h) (fmol/ml/?. h) 
vehicle 
/Y-EP 
o-MSH, 
/%EP+a-MSH, 
ACTH: 
j9-EP+ACTHz 
a.MSH,+ACTH, 
&EP+a-MSH,+ACTHz 
(A) 150.7 (l3)* 
[5.016 f 0.003] 
(I)) lG4.5 (12) 
[5.103 t 0.0035] 
(C) 182.3 (12) 
[5.206 f O.OOG2] 
(D) 185.4 (II) 
[5.223 f 0.0030] 
(E) 5369 (I I) 
[6.286 I- 0.019] 
(F) 6G5.6 (IO) 
[6.501 2 0.0311 
(G) 714.0 (11) 
[6.571 1 O.OlO] 
(H) 680.8 (12) 
IG.524 2 0.014] 
(I) 2493 (12) 
[7.821 2 O.OOGG] 
(J) 2326 (I 2) 
[7.752 2: 0,0096] 
(K) 2675 (I’) 
[7.393 ?: 0.0097] 
(L) 2092 (I 3) 
[7.646 r 0.0041] 
(M) 8497 (12) 
[9,048 f 0,0094] 
(N) 6623 (I 2) 
[8.798 P O.Ol4] 
(0) 9185 (12) 
[9.125 f 0.0351 
(P) G920 (I 2) 
[8.842 1- 0.0028] 
Values are geometric means of data; n is given in parcnthescs; [arith- 
metic mwls and SE of log data]. 
doses: ,&EP: lo”” M, a-MSH,: IO” M, ACTH,: I,Gxlo”” M 
P < 0.05: G-H. I-J. 
P c 0.01: A-B, A-C, B-D, E-F, E-G, A-E, B-F, C-G, D-H, K-L, I-K, 
J-L, M-N, O-P, M-O, I-M, J-N, K-O. L-P. 
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taneous secretion of the other peptidcs from the same 
precursor. This raises the possibility that differential 
posttranslational processing of POMC may serve as a 
regulator of adrenocortical steroid secretion. The po- 
tentiating effect of a-MSH, or both the potentiating and 
the inhibitory effect of j%EP on corticosteroidogenesis, 
may be of greater importance in various situations when 
there is a dissociation of ACTH, a-MSH and /I-EP 
release. This can occur in certain forms of stress (e.g. 
emotional stress) when the ncurointermediate lobe of 
the pituitary is stimulated 1163, where POMC processing 
differ from that in the anterior lobe (the anterior pitui- 
tary corticotrophs process the POMC molecule to syn- 
thesize ACTH, j?-LPH and to a lesser extent/I-EP, while 
the intermediate lobe processes the molecule further to 
synthesize a-MSM and ,S-EP), or after dexamethasone 
pretreatment, when ACTH release is blocked, but a- 
MSH release is not affected [17]. 
In conclusion, WC can only agree with Bertolini [18], 
who suggested 10 years ago that ‘endorphins-enkepha- 
lins and ACTH-MSH peptides might have opposite and 
mutually balancing effects on several functions linked 
to the reactions of higher organisms to the changes of 
the environment...‘. 
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